Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/41551
Título : Nanobioconjugates for targeted delivery of antigenic and therapeutic peptides at colorectal cancer
Autor : Urrea Tavera, Cristian Stalyn
Mejía de los Ríos, Susana Pamela
Orozco Holguín, Jahir
metadata.dc.subject.*: Neoplasias Colorrectales
Colorectal Neoplasms
Péptidos
Peptides
Antígenos
Antigens
Nanopartículas
Nanoparticles
Copolímero de Ácido Poliláctico-Ácido Poliglicólico
Polylactic Acid-Polyglycolic Acid Copolymer
Receptores CCR
Receptors, CCR
Nanobioconjugado
https://id.nlm.nih.gov/mesh/D015179
https://id.nlm.nih.gov/mesh/D010455
https://id.nlm.nih.gov/mesh/D000941
https://id.nlm.nih.gov/mesh/D053758
https://id.nlm.nih.gov/mesh/D000077182
https://id.nlm.nih.gov/mesh/D054388
metadata.dc.contributor.conferencename: International Student Congress Of (bio)Medical Sciences, ISCOMS 2024 (del 3 al 7 de junio de 2024 : University Medical Center Groningen, Groningen, Países Bajos)
Fecha de publicación : 4-jun-2024
Resumen : ABSTRACT: Colorectal cancer (CRC) presents challenges due to the limited effectiveness and side effects of conventional treatments like chemotherapy and surgery. Nanobioconjugates, such as poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NPs), offer improved drug delivery alternatives. Peptides bonded to CRC receptors show potential as therapies and vaccines. This study encapsulates the P1 peptide in PLGA-PEG-Mal NPs, functionalized with the G3 peptide for targeted CRC cell delivery to inhibit cell proliferation1,2, and encapsulates the P2 peptide in PLGA-COOH polymer to inhibit tumor growth via CD8+ T-cell activation, using D-mannosamine for targeting antigen-presenting cells 3,4. By studying the physicochemical properties of PLGA and peptides, the research aims to enhance stability and controlled release while minimizing side effects and improving CRC therapy from nanobioconjugates and peptide synergies.
Aparece en las colecciones: Documentos de conferencias en Ciencias Exactas y Naturales

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
UrreaCristian_2024_Nanobioconjugates_Targeted_Antigenic.pdfPóster de conferencia925.12 kBAdobe PDFVisualizar/Abrir
UrreaCristian_2024_Nanobioconjugates_Targeted_Antigenic-Resumen.pdfResumen145.62 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons